Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Post by Ticklel1ston Aug 02, 2020 10:41am
200 Views
Post# 31355277

Some neat things to wonder about over the years..

Some neat things to wonder about over the years..So here are some observations that maybe the EU group might have missed because they are so smart according to Waxie…

A question about Casper Bych  who resigned from the board on June 12, 2019 (at least it was announced on June 12th).  After he resigned, it looks like there one independent director on the board looking after shareholders. That would be Alex Marazzi? Is there not least two independent directors for needed audit committee. That should not include their Chinese lawyer Tran. I don’t think he is considered independent.

Another question.  CFO Chris Hopton is on the board. Should he hold a BofD position? Should he also be on the compensation committee? Why would you have the CFO on the compensation committee? The fact the CEO is also on the compensation committee and that the CEO and CFO would have a majority of the votes on that committee seems to stack the Compensation committee with non- independant members. And Tran is on there as well. Not sure how independent Tran is??

Look at Sirona's financial statements in Sedar dated June 28/19.  Casper Bych, who resigned and  was announced on June 12th NR, signed the financial statements which were dated and filed on SEDAR on June 28, 2019. He was not on the board on June 28th. How can he sign financial statements when he was not on the BofD at the time?
 
Back in Sedar again. Michael Rogers signed the 2018 Q3 financial statement filed on SEDAR on October 1, 2018. But there is a NR that  he resigned on May 1, 2015. How can Michael Rogers sign Sirona's financial statements more than three years after he resigned?? How does that happen?

Sedar shows interim financial statements filed on June 26, 2018 and March 27, 2018 were not signed by anybody. Should not the CFO find time to go over them and sign them? I know he is busy with a number of other jobs, but is not signing intrim financial ensuring he is  doing a diligent partime job for Sirona and shareholders for the salary , options and bonuses?

<< Previous
Bullboard Posts
Next >>